Autophagy meets fused in sarcoma-positive stress granules
Author
dc.contributor.author
Matus, Soledad
Author
dc.contributor.author
Bosco, Daryl A.
es_CL
Author
dc.contributor.author
Hetz Flores, Claudio
es_CL
Admission date
dc.date.accessioned
2014-12-11T12:57:47Z
Available date
dc.date.available
2014-12-11T12:57:47Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
Neurobiology of Aging 35 (2014) 2832-2835
en_US
Identifier
dc.identifier.other
dx.doi.org/10.1016/j.neurobiolaging.2014.08.019
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129336
General note
dc.description
Articulo de publicación SCOPUS
en_US
Abstract
dc.description.abstract
Mutations in fused in sarcoma and/or translocated in liposarcoma (FUS, TLS or FUS) are linked to familial
cases of amyotrophic lateral sclerosis (ALS). Mutant FUS selectively accumulates into discrete cytosolic
structures known as stress granules under various stress conditions. In addition, mutant FUS expression
can alter the dynamics and morphology of stress granules. Although the link between mutant FUS and
stress granules is well established, the mechanisms modulating stress granule formation and disassembly
in the context of ALS are poorly understood. In this issue of Neurobiology of Aging, Ryu et al.
uncover the impact of autophagy on the potential toxicity of mutant FUS-positive stress granules. The
authors provide evidence indicating that enhanced autophagy activity reduces the number of stress
granules, which in the case of cells containing mutant FUS-positive stress granules, is neuroprotective.
Overall, this study identifies an intersection between the proteostasis network and alterations in RNA
metabolism in ALS through the dynamic assembly and disassembly of stress granules.
en_US
Patrocinador
dc.description.sponsorship
FONDECYT, National Institutes of Health
and National Institute of Neurological Disorders and Stroke; ALS Therapy Alliance and CVS
Pharmacy; and Worcester Foundation